Defender Capital’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.4K | Sell |
32,928
-11,450
| -26% | -$34.6K | 0.03% | 38 |
|
|
2025
Q1 | $127K | Sell |
44,378
-2,700
| -6% | -$7.72K | 0.05% | 34 |
|
|
2024
Q4 | $112K | Sell |
47,078
-12,275
| -21% | -$29.2K | 0.04% | 37 |
|
|
2024
Q3 | $169K | Buy |
59,353
+4,133
| +7% | +$11.8K | 0.06% | 34 |
|
|
2024
Q2 | $163K | Sell |
55,220
-665
| -1% | -$1.96K | 0.06% | 34 |
|
|
2024
Q1 | $164K | Sell |
55,885
-15,765
| -22% | -$46.2K | 0.06% | 35 |
|
|
2023
Q4 | $179K | Sell |
71,650
-42,870
| -37% | -$107K | 0.06% | 35 |
|
|
2023
Q3 | $357K | Sell |
114,520
-1,877
| -2% | -$5.86K | 0.13% | 27 |
|
|
2023
Q2 | $535K | Sell |
116,397
-1,775
| -2% | -$8.16K | 0.18% | 24 |
|
|
2023
Q1 | $838K | Buy |
118,172
+4,525
| +4% | +$32.1K | 0.29% | 19 |
|
|
2022
Q4 | $729K | Sell |
113,647
-13,952
| -11% | -$89.5K | 0.29% | 17 |
|
|
2022
Q3 | $1.88M | Sell |
127,599
-1,870
| -1% | -$27.6K | 0.74% | 15 |
|
|
2022
Q2 | $2.33M | Buy |
129,469
+1,362
| +1% | +$24.5K | 0.91% | 14 |
|
|
2022
Q1 | $4M | Buy |
128,107
+17,267
| +16% | +$539K | 1.39% | 13 |
|
|
2021
Q4 | $4.81M | Buy |
110,840
+12,799
| +13% | +$556K | 1.54% | 13 |
|
|
2021
Q3 | $6.94M | Buy |
98,041
+30,681
| +46% | +$2.17M | 2.26% | 12 |
|
|
2021
Q2 | $7.73M | Buy |
67,360
+37,137
| +123% | +$4.26M | 2.57% | 11 |
|
|
2021
Q1 | $3.12M | Buy |
+30,223
| New | +$3.12M | 1.11% | 14 |
|